îæ€çŽ¢
îæ€çŽ¢
î
Y-mAbs Therapeutics Inc
YMABîãŠã©ãããªã¹ãã«è¿œå
8.610USD
0.0000.00%
çµå€Â 06/18, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
391.22Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
æ ªäž»
æŽæ°æå»: Mon, Aug 25
æŽæ°æå»: Mon, Aug 25
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
WG Biotech ApS
10.03%
Paradigm BioCapital Advisors LP
9.32%
Beryl Capital Management, LLC
8.99%
HBM Partners AG
7.26%
Acorn Capital Advisors, LLC
6.15%
ä»ã®
58.24%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
WG Biotech ApS
10.03%
Paradigm BioCapital Advisors LP
9.32%
Beryl Capital Management, LLC
8.99%
HBM Partners AG
7.26%
Acorn Capital Advisors, LLC
6.15%
ä»ã®
58.24%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Individual Investor
0.10%
ä»ã®
99.90%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Tue, Jul 1
æŽæ°æå»: Tue, Jul 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q2
265
37.68M
82.95%
-1.02M
2025Q1
277
38.42M
85.49%
-1.59M
2024Q4
273
40.45M
90.45%
-6.61K
2024Q3
291
40.17M
90.02%
+2.08M
2024Q2
285
38.93M
87.51%
+1.55M
2024Q1
287
37.98M
86.27%
+2.28M
2023Q4
288
35.14M
80.00%
-1.12M
2023Q3
292
32.75M
75.02%
-3.59M
2023Q2
292
32.24M
73.87%
-4.59M
2023Q1
293
31.07M
71.14%
-6.37M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
ããŒã¿ãªã
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Sep 6
æŽæ°æå»: Sat, Sep 6
éæå
æ¯ç
iShares Russell 2000 Growth ETF
0%
Schwab U.S. Broad Market ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Proshares Ultra Russell 2000
0%
ALPS Medical Breakthroughs ETF
0%
iShares Micro-Cap ETF
0%
iShares Russell 3000 ETF
0%
ProShares UltraPro Russell2000
0%
DFA Dimensional US Core Equity Market ETF
0%
AltShares Merger Arbitrage ETF
0%
詳现ãèŠã
iShares Russell 2000 Growth ETF
æ¯ç0%
Schwab U.S. Broad Market ETF
æ¯ç0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
æ¯ç0%
Proshares Ultra Russell 2000
æ¯ç0%
ALPS Medical Breakthroughs ETF
æ¯ç0%
iShares Micro-Cap ETF
æ¯ç0%
iShares Russell 3000 ETF
æ¯ç0%
ProShares UltraPro Russell2000
æ¯ç0%
DFA Dimensional US Core Equity Market ETF
æ¯ç0%
AltShares Merger Arbitrage ETF
æ¯ç0%
